BIOVIE
BioVie is pioneering an innovative therapeutic approach targeting ascites due to liver cirrhosis. Ascites, or the accumulation of fluid in the abdomen, is the most common complication of cirrhosis due to NASH (non-alcoholic steatohepatitis), alcoholic liver disease and/or hepatitis C. Ascites affects about 100,000 Americans and many times more worldwide, and contributes substantially to mortality. Our therapy BIV201 is based on a drug that is not yet available in the US but is approved in about... 50 countries to treat related complications of liver cirrhosis. The Company, formerly knows as NanoAntibiotics, Inc., recently acquired LAT Pharma LLC. This merger provided our lead development program, BIV201. Following a pre-investigational new drug meeting (“pre-IND”) with the FDA in early 2016, the Company is now assembling its IND package, and may commence a US clinical trial as early as 2017.
BIOVIE
Industry:
Biotechnology Health Care Innovation Management Therapeutics Wellness
Founded:
2013-01-01
Address:
Beverly, Massachusetts, United States
Country:
United States
Website Url:
http://www.biovieinc.com
Total Employee:
1+
Status:
Active
Contact:
(312)283-5793
Total Funding:
47.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS GoDaddy Bizo
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Kodiak Sciences
Kodiak is designing and developing novel therapies for the treatment of retinal disease.
Nascent Biotech
Nascent Biotech is a biotechnology company building a portfolio of innovative therapeutic antibodies.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Board_member
2016-12-16
Current Employees Featured
Rajah Menon President @ BioVie
President
Terren Peizer Chairman & CEO @ BioVie
Chairman & CEO
2018-06-01
Joseph M. Palumbo CMO @ BioVie
CMO
2021-10-01
Elliot Ehrlich Chief Executive Officer @ BioVie
Chief Executive Officer
Jonathan Adams Chief Executive Officer @ BioVie
Chief Executive Officer
2016-01-01
Amrit Shahzad President @ BioVie
President
Penelope Markham Chief Scientific Officer @ BioVie
Chief Scientific Officer
Jonathan Adams President & COO @ BioVie
President & COO
2018-07-01
Cuong Do Founder, President & CEO @ BioVie
Founder, President & CEO
2013-01-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-04-18 | LAT Pharma | LAT Pharma acquired by BioVie | N/A |
Investors List
Avenue Capital Group
Avenue Capital Group investment in Post-IPO Debt - BioVie
Key Employee Changes
Official Site Inspections
http://www.biovieinc.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "BioVie"
BioVie Inc. - Investor Relations
Nov 20, 2024 BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (Alzheimer's …See details»
Bioviepharma
BioVie believes that inflammation is central to the development and progression of Alzheimer’s disease. BioVie’s different approach focuses on our novel molecule, bezisterim, currently …See details»
BioVie - Crunchbase Company Profile & Funding
BioVie is pioneering an innovative technology. BioVie is a purpose-driven company. BioVie develops new solutions to help people live healthier and …See details»
BioVie Inc. (BIVI) Company Profile & Facts - Yahoo Finance
Feb 11, 2022 BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The …See details»
BioVie Org Chart + Executive Team - The Official Board
For each of our 1,295,287 listed executives, discover their exact roles and their biographies.See details»
BioVie Inc. - LinkedIn
BioVie Inc. | 2,351 followers on LinkedIn. Developing innovative therapies for the treatment of neurodegenerative conditions and advanced liver disease. | Focusing on Finding Solutions for ...See details»
BioVie Inc. - Governance - Governance Documents
680 W. Nye Lane, Suite 201 Carson City, NV 89703. info@bioviepharma.comSee details»
BioVie - Org Chart, Teams, Culture & Jobs | The Org
View BioVie's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
BioVie Company Profile | Management and Employees List
Find contact information for BioVie. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and BioVie's email format.See details»
BioVie Inc. Company Profile & Data: stocks, market cap, financials ...
BioVie Inc. market capitalization over time Evolution of BioVie Inc. market cap in the past 5 years Market capitalizations are calculated from the opening stock price at the beginning of each …See details»
BioVie Inc. - Governance - Committee Composition
680 W. Nye Lane, Suite 201 Carson City, NV 89703 [email protected]See details»
BioVie Inc. - Resources - Investor FAQs
680 W. Nye Lane, Suite 201 Carson City, NV 89703. info@bioviepharma.comSee details»
Organization: BioVie - Cbonds.com
Organization name. BioVie Inc. Country name. USA Country of registration. USA. Industry. Pharmaceutical Preparation and Biotechnology. Bond debt - Find Any Data on Any Bond in …See details»
BioVie - Overview, News & Similar companies | ZoomInfo.com
BioVie Inc. is a pharmaceutical company that is pioneering treatment for patients suffering from Ascites. BioVie's Social Media. Is this data correct? View contact profiles from BioVie. Popular …See details»
Alzheimer's Disease - BioVie Pharma
BioVie's perspective centers on inflammation as the core driver behind Alzheimer's disease development and progression. BioVie takes a distinctive approach by focusing on an …See details»
BioVie Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 BioVie (formerly knows as NanoAntibiotics) is a therapeutical company developing approaches targeting ascites due to liver cirrhosis. The company's developed therapy BIV201 …See details»
BioVie Inc. - Financials - SEC Filings
Date Filing Type Filing Description Download / View; SEC Filings documents grouped by date, type, and descriptionSee details»
BioVie Inc. Secures $3 Million in Latest Public Offering to Advance ...
Sep 25, 2024 In a significant step forward for a company dedicated to addressing chronic debilitating conditions, BioVie Inc. (Nasdaq: BIVI) has successfully closed a public offering …See details»
BioVie Prices Public Offering Of 2.50 Mln Shares At $8.00/shr
Aug 9, 2021 (RTTNews) - BioVie Inc. (BIVI) said that it has priced its underwritten public offering of 2.50 million shares of its Class A common stock at a public offering price of $8.00 per share, …See details»
BioVie Inc. - Stock Info
Feb 19, 2025 680 W. Nye Lane, Suite 201 Carson City, NV 89703. info@bioviepharma.comSee details»